Literature DB >> 24225280

Trocar site hernia on an 8-mm port following robotic-assisted hysterectomy.

Gokhan Sami Kilic1, Tevfik Berk Bildaci2, Omer Lutfi Tapisiz3, Ibrahim Alanbay4, Teresa Walsh1, Olga Swanson1.   

Abstract

The increasing use of laparoscopy has resulted in added complications specific to the laparoscopic approach, such as trocar site hernia (TSH), which is an uncommon but well-recognized problem for both regular laparoscopic and robotic-assisted laparoscopic procedures. We describe an extremely rare case of TSH at an 8-mm port site occurring a relatively short time after surgery in a 53-year-old patient undergoing robotic-assisted laparoscopic hysterectomy for benign reasons. Additionally, this report attempts to explain the possible etiological factors relating to TSH following robotic-assisted surgery. According to our case report, a defect in the 8-mm port that may lead to hernia is one possible explanation, and closure of the 8-mm trocar sites' fascia may be a safer approach during robotic-assisted surgery. Additional reports are needed to accurately determine the frequency of occurrence and importance of this complication.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  complication; hernia; hysterectomy; robotic; trocar

Mesh:

Year:  2013        PMID: 24225280     DOI: 10.1016/j.jcma.2013.10.003

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  2 in total

1.  Port-site incisional hernia from an 8-mm robotic trocar following robot-assisted radical cystectomy: Report of a rare case.

Authors:  Shoko Uketa; Yousuke Shimizu; Kosuke Ogawa; Noriaki Utsunomiya; Sojun Kanamaru
Journal:  IJU Case Rep       Date:  2020-03-21

2.  Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer.

Authors:  Maria B Schiavone; Maciej S Bielen; Ginger J Gardner; Oliver Zivanovic; Elizabeth L Jewell; Yukio Sonoda; Richard R Barakat; Dennis S Chi; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2016-01-08       Impact factor: 5.482

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.